4266 Federal Register / Vol. 80, No. 17 / Tuesday, January 27, 2015 / Notices 

7Per industry sources, most fur labeling is done 

in the United States. This rate is reflective of an 

average domestic hourly wage for such tasks 

performed in the United States, which is derived 

from recent BLS statistics. 8Although items previously exempt from the 

labeling requirements must now be labeled 

regarding their fur content, the Textile and Wool 

Rules, found at 16 CFR part 303 and 16 CFR part 

300, respectively, already required many such items 

to have fiber content labels. Hence, manufacturers 

likely have in place the equipment needed to 

comply with the additional labeling requirements. 

Task Hourly rate Burden hours Labor cost 

Determine label content ............................................................................................. $ 26.00 39,600 $1,029,600 

Draft and order labels ................................................................................................ 17.00 13,200 224,400 

Attach labels .............................................................................................................. 7 10.00 54,785 547,850 

Invoice disclosures .................................................................................................... 17.00 28,316 481,372 

Prepare advertising disclosures ................................................................................ 26.00 49,200 1,279,200 

Recordkeeping ........................................................................................................... 17.00 64,440 1,095,480 

Total .................................................................................................................... .............................. .............................. 4,657,902 

Staff believes that there are no current 

start-up costs or other capital costs 

associated with the Fur Rules. Because 

the labeling of fur products has been an 

integral part of the manufacturing 

process for decades, manufacturers have 

in place the capital equipment 

necessary to comply with the Rules’ 

labeling requirements.8 Industry sources 

indicate that much of the information 

required by the Fur Act and Rules 

would be included on the product label 

even absent the Rules. Similarly, 

invoicing, recordkeeping, and 

advertising disclosures are tasks 

performed in the ordinary course of 

business so that covered firms would 

incur no additional capital or other nonlabor costs as a result of the Act or the 

Rules. 

Request for Comments 

You can file a comment online or on 

paper. Write ‘‘Fur Rules: FTC File No. 

P074201’’ on your comment. Your 

comment—including your name and 

your state—will be placed on the public 

record of this proceeding, including, to 

the extent practicable, on the public 

Commission Web site, at http://

www.ftc.gov/os/publiccomments.shtm. 

As a matter of discretion, the 

Commission tries to remove individuals’ 

home contact information from 

comments before placing them on the 

Commission Web site. 

Because your comment will be made 

public, you are solely responsible for 

making sure that your comment does 

not include any sensitive personal 

information, such as a Social Security 

number, date of birth, driver’s license 

number or other state identification 

number or foreign country equivalent, 

passport number, financial account 

number, or credit or debit card number. 

You are also solely responsible for 

making sure that your comment does 

not include any sensitive health 

information, such as medical records or 

other individually identifiable health 

information. In addition, do not include 

any ‘‘[t]rade secret or any commercial or 

financial information which is . . . 

privileged or confidential,’’ as discussed 

in Section 6(f) of the FTC Act, 15 U.S.C. 

46(f), and FTC Rule 4.10(a)(2), 16 CFR 

4.10(a)(2). In particular, do not include 

competitively sensitive information 

such as costs, sales statistics, 

inventories, formulas, patterns, devices, 

manufacturing processes, or customer 

names. 

If you want the Commission to give 

your comment confidential treatment, 

you must file it in paper form, with a 

request for confidential treatment, and 

you must follow the procedure 

explained in FTC Rule 4.9(c), 16 CFR 

4.9(c). Your comment will be kept 

confidential only if the FTC General 

Counsel, in his or her sole discretion, 

grants your request in accordance with 

the law and the public interest. Postal 

mail addressed to the Commission is 

subject to delay due to heightened 

security screening. As a result, the 

Commission encourages you to submit 

your comments online. To make sure 

that the Commission considers your 

online comment, you must file it at 

https://ftcpublic.commentworks.com/

ftc/furrulespra by following the 

instructions on the web-based form. If 

this Notice appears at http://

www.regulations.gov, you also may file 

a comment through that Web site. 

If you file your comment on paper, 

write ‘‘Fur Rules: FTC File No. 

P074201’’ on your comment and on the 

envelope, and mail it to the following 

address: Federal Trade Commission, 

Office of the Secretary, 600 

Pennsylvania Avenue NW., Suite CC– 

5610, (Annex J), Washington, DC 20580, 

or deliver your comment to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

Constitution Center, 400 7th Street SW., 

5th Floor, Suite 5610, (Annex J), 

Washington, DC 20024. If possible, 

submit your paper comment to the 

Commission by courier or overnight 

service. 

The FTC Act and other laws that the 

Commission administers permit the 

collection of public comments to 

consider and use in this proceeding as 

appropriate. The Commission will 

consider all timely and responsive 

public comments that it receives on or 

before March 30, 2015. You can find 

more information, including routine 

uses permitted by the Privacy Act, in 

the Commission’s privacy policy, at 

http://www.ftc.gov/ftc/privacy.htm. 

David C. Shonka, 

Principal Deputy General Counsel. 

[FR Doc. 2015–01430 Filed 1–26–15; 8:45 am] 

BILLING CODE 6750–01–P 

FINANCIAL STABILITY OVERSIGHT 

COUNCIL 

Proposed Collections; Comment 

Requests 

ACTION: Notice and request for 

comments. 

SUMMARY: The Financial Stability 

Oversight Council (the ‘‘Council’’) 

invites members of the public and 

affected agencies to comment on 

continuing information collections, as 

required by the Paperwork Reduction 

Act of 1995, Public Law 104–13 (44 

U.S.C. 3506(c)(2)(A)). The Council is 

soliciting comments concerning its 

extension of a currently approved 

collection of information related to its 

authority to determine that certain 

nonbank financial companies shall be 

subject to supervision by the Board of 

Governors of the Federal Reserve 

System (Board of Governors) and 

enhanced prudential standards. Section 

113 of the Dodd-Frank Wall Street 

Reform and Consumer Protection Act 

(the ‘‘Dodd-Frank Act’’) provides the 

Council the authority to determine that 

a nonbank financial company shall be 

subject to Board of Governors 

supervison and enhanced prudential 

standards if the Council determines that 

material financial stress at the nonbank 

financial company, or the nature, scope, 

size, scale, concentration, 


asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 17 / Tuesday, January 27, 2015 / Notices 4267 

interconnectedness, or the mix of 

activities of the nonbank financial 

company, could pose a threat to 

financial stability. On April 11, 2012, 

the Council published in the Federal 

Register a final rule and interpretive 

guidance (77 FR 21637), 12 CFR part 

1310, that describe the manner in which 

the Council intends to apply the 

statutory standards and considerations, 

and the processes and procedures the 

Council intends to follow, in making 

determinations under Section 113 of the 

Dodd-Frank Act. The Council has made 

final determinations regarding four 

nonbank financial companies. The 

Council uses information collected 

under 12 CFR 1310.20 to assess whether 

a nonbank financial company meets the 

standards for a Council determination 

under Section 113 of the Dodd-Frank 

Act. The collection of information under 

12 CFR 1310.21 affords a nonbank 

financial company an opportunity to 

submit materials to contest the 

Council’s consideration of the company 

for a proposed determination and to 

contest a proposed determination. The 

collection of information in 12 CFR 

1310.22 provides a nonbank financial 

company an opportunity to contest the 

Council’s waiver or modification of the 

notice or other procedural requirements 

contained in 12 CFR 1310.21 by 

requesting a hearing. The Council uses 

information collected under 12 CFR 

1310.23 in a reevaluation of its 

determination regarding a nonbank 

financial company subject to a Council 

determination. 

DATES: Written comments must be 

received on or before March 30, 2015 to 

be assured of consideration. 

ADDRESSES: You may submit comments 

by any of the following methods: 

Mail: Attn: Request for Comments 

(Financial Stability Oversight Council 

Proposed Information Collection), Office 

of the Financial Stability Oversight 

Council, Department of the Treasury, 

1500 Pennsylvania Avenue NW., 

Washington, DC 20220. 

Electronic Submission: 

FSOC.Comments@treasury.gov. 

Instructions: All submissions received 

must include the agency name and the 

Federal Register document number that 

appears at the end of this document. 

Comments received will be made 

available to the public via 

regulations.gov without change, and 

including any personal information 

provided. 

FOR FURTHER INFORMATION CONTACT: 

Requests for additional information 

about the filings or procedures should 

be directed to Executive Director, 

Financial Stability Oversight Council, 

Department of the Treasury, 1500 

Pennsylvania Avenue NW., Washington, 

DC 20220. 

SUPPLEMENTARY INFORMATION: 

Title: Determinations Regarding 

Certain Nonbank Financial Companies. 

OMB Control Number: 1505–0244. 

Abstract: The Council uses 

information collected under 12 CFR 

1310.20 to assess whether a nonbank 

financial company meets the standards 

for a Council determination under 

Section 113 of the Dodd-Frank Act. The 

collection of information under 12 CFR 

1310.21 affords a nonbank financial 

company an opportunity to submit 

materials to contest the Council’s 

consideration of the company for a 

proposed determination and to contest a 

proposed determination. The collection 

of information in 12 CFR 1310.22 

provides a nonbank financial company 

an opportunity to contest the Council’s 

waiver or modification of the notice or 

other procedural requirements 

contained in 12 CFR 1310.21 by 

requesting a hearing. The Council uses 

information collected under 12 CFR 

1310.23 in its reevaluation of a 

determination regarding a nonbank 

financial company subject to a Council 

determination. 

Type of Review: Extension of a 

currently approved collection. 

Affected Public: Nonbank financial 

companies. 

Estimated Total Annual Burden 

Hours for all Collections: 500 hours. 

Request for Comments: Comments 

submitted in response to this notice will 

be summarized or included in the 

request for OMB approval. All 

comments will become a matter of 

public record. Comments are invited on: 

(a) Whether the collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information has practical utility; (b) the 

accuracy of the agency’s estimate of the 

burden of the collection of information; 

(c) ways to enhance the quality, utility, 

and clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. 

David G. Clunie, 

Executive Secretary. 

[FR Doc. 2015–00860 Filed 1–26–15; 8:45 am] 

BILLING CODE 4810–25–P–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Findings of Research Misconduct 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the Office of Research Integrity (ORI) 

has taken final action in the following 

case: 

Dong Xiao, Ph.D., University of 

Pittsburgh: Based on the report of an 

inquiry conducted by the University of 

Pittsburgh (UP), additional analysis 

conducted by ORI in its oversight 

review, and an admission by the 

Respondent that he had ‘‘intentionally 

fabricated data contained in a paper 

entitled ‘Guggulsterone inhibits prostate 

cancer growth via inactivation of Akt 

regulated by ATP citrate signaling,’ 

specifically Figure 6G,’’ ORI found that 

Dr. Dong Xiao, former Research 

Assistant Professor, Department of 

Urology, UP, engaged in research 

misconduct in research supported by 

National Cancer Institute (NCI), 

National Institutes of Health (NIH), 

grant R01 CA157477. 

ORI found that Respondent engaged 

in research misconduct by reporting 

falsified data in Figures 1, 4, 5, S2, and 

S3 in the following paper published 

online: 

• Gao, Y., Zeng, Y., Tian, J., Kslam, 

M.S., Jiang, G., & Xiao, D., 

‘‘Gugglesterone inhibits prostate cancer 

growth via inactivation of Akt regulated 

by ATP citrate signaling.’’ Oncotarget, 

June 26, 2014 [Epub ahead of print], 

PMID: 24980815; hereafter referred to as 

the ‘‘Oncotarget paper.’’ 

Specifically, in the Oncotarget paper, 

Respondent: 

• Falsely stated that 10 mice per group 

were used to obtain data for tumor 

volume (Figure 1A) and tumor weight 

(Figure 1B) when data for only four 

mice per group were available 

• falsified the results for C-caspase 3 

and phosphorylated Akt in the 

Western blots presented in Figure 1D 

to claim that treatment of tumor 

bearing mice with Z-Gug significantly 

enhanced C-capase 3 activity and 

significantly inhibited Akt 

phorphorylation, while the original 

data showed no significant effect for 

either activity 

• falsified Figure 4C by manipulating pAkt bands to show that Z-Gug alone 

and in combination with PHTM 

significantly inhibited Akt 

phosphorylation in PC3 and LNCaP 

human prostate cancer cell lines; the 


asabaliauskas on DSK5VPTVN1PROD with NOTICES